… Thrombolytic therapy involves thrombolytic agents administered to patients suffering from …
The therapy induces systemic effects interrelated with the thrombolytic agent used. Bleeding …

… disease, and the subject of chemical thrombolysis have received more limited attention (in
many … obtained when therapy was instituted within a few days of onset of the thrombotic event. …

… the blood flow in acute thrombotic events, however, they are … for the management of thrombotic
diseases remains an open … improve both the efficacy and safety of thrombolytic therapy. …

… or isolated calf DVT should not undergo thrombolytic therapy since the risk of developing
PTS is very low [42]. At present, thrombolytic therapy is discouraged in most patients with DVT …

… Thrombolytic treatment, also known as fibrinolytic therapy, dissolves dangerous intravascular
… Thromboembolism has the following clinical outcomes where thrombolytic therapy can be …

… that although intravenous thrombolytic therapy was safe and … in 1996, intravenous thrombolytic
therapy for acute ischemic … patient subgroups respond to thrombolytic therapy, we should …

… Anticoagulation and thrombolytic therapies are the mainstay of … will allow for more
effective tailored therapy for VT (5). … As a thrombus matures, fibrosis can cause post-thrombotic …

Background : The long-term effect of thrombolytic treatment of pulmonary embolism (PE) is
unknown. Objectives : This study investigated the long-term prognosis of patients with …

… vascular imaging delayed the advancements in thrombolytic and stroke therapy. In 1976, 31
… that thrombolytic therapy might present. The need for a more thrombus-specific thrombolytic …

… Numerous clinical trials for thrombolytic drugs, which aimed to pharmacologically dissolve
thrombi, were conducted in the 1950s, when the first thrombolytic therapy was performed. …